Correlation Between Tarsus Pharmaceuticals and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Tscan Therapeutics, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Tscan Therapeutics.
Diversification Opportunities for Tarsus Pharmaceuticals and Tscan Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Tarsus and Tscan is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Tscan Therapeutics
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.71 times more return on investment than Tscan Therapeutics. However, Tarsus Pharmaceuticals is 1.4 times less risky than Tscan Therapeutics. It trades about 0.28 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 3,967 in Tarsus Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 857.00 from holding Tarsus Pharmaceuticals or generate 21.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Tscan Therapeutics
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Tscan Therapeutics |
Tarsus Pharmaceuticals and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Tscan Therapeutics
The main advantage of trading using opposite Tarsus Pharmaceuticals and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |